Biofermin (4517 JP) - Taisho (4581 JP): Merger Is a Done Deal
Taisho Pharma and subsidiary Biofermin (4517) have agreed to merge. The vote looks like a done deal. This is a short-dated rate of return trade.
🇯🇵 JAPAN • Results & Revisions 01/21 Capcom, Infomart, ISI-D
As we move towards the beginning of the disclosure season for the March/June/September/ December cohort of companies, several companies are...
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
No more insights